Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.

<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methyl...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ibrahim Musa Yola, Carlee Moser, Meredith S Duncan, Edzard Schwedhelm, Dorothee Atzler, Renke Maas, Juliane Hannemann, Rainer H Böger, Ramachandran S Vasan, Vanessa Xanthakis
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/ceb4479eea9640919734a6f24a35e397
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!